ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
88 hedge funds and large institutions have $228M invested in ChemoCentryx, Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
32% more capital invested
Capital invested by funds: $173M → $228M (+$55.4M)
5% more funds holding
Funds holding: 84 → 88 (+4)
7% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 29
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $103K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.89M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.54M |
| 3 |
BlackRock
New York
|
+$1.28M |
| 4 |
Renaissance Technologies
New York
|
+$782K |
| 5 |
BTS
BB&T Securities
Richmond,
Virginia
|
+$613K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$986K |
| 2 |
CFIC
City Financial Investment Company
London,
United Kingdom
|
-$566K |
| 3 |
Franklin Resources
San Mateo,
California
|
-$541K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$494K |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$369K |
CCXI Hedge Fund Activity: Q2 2017 in Review
88 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2017, worth a combined $228M — up 32% from $173M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CCXI positions and 7 closed out — a net gain of 4 holders — while 31 added to existing stakes and 29 trimmed.
The largest buyer was BVF Inc, adding an estimated $1.89M. The largest seller was Invesco, cutting an estimated $986K.
- 88 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2017, up from 84 in Q1 2017.
- Funds reported $228M of ChemoCentryx, Inc. stock for Q2 2017, up 32% quarter-over-quarter.
- 11 funds opened new ChemoCentryx, Inc. positions in Q2 2017 and 7 closed out, a net change of +4 holders.
- The largest ChemoCentryx, Inc. buyer in Q2 2017 was BVF Inc, an estimated $1.89M added.
- The largest ChemoCentryx, Inc. seller in Q2 2017 was Invesco, an estimated $986K sold.
Based on aggregated 13F filings for Q2 2017.